11/7
08:36 am
prax
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $151.00 price target on the stock.
Low
Report
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $151.00 price target on the stock.
11/7
08:36 am
prax
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
Low
Report
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
11/7
04:30 am
prax
Rating for PRAX
Medium
Report
Rating for PRAX
11/7
04:30 am
prax
Rating for PRAX
Medium
Report
Rating for PRAX
10/31
01:05 pm
prax
Rating for PRAX
Low
Report
Rating for PRAX
10/31
01:05 pm
prax
Rating for PRAX
Low
Report
Rating for PRAX
9/10
08:01 am
prax
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
Low
Report
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
9/5
06:20 am
prax
Rating for PRAX
Low
Report
Rating for PRAX
9/5
06:20 am
prax
Rating for PRAX
Low
Report
Rating for PRAX
9/4
11:03 am
prax
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $143.00 price target on the stock, up previously from $134.00.
Medium
Report
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $143.00 price target on the stock, up previously from $134.00.
9/4
10:11 am
prax
Rating for PRAX
Medium
Report
Rating for PRAX
9/4
10:11 am
prax
Rating for PRAX
Medium
Report
Rating for PRAX
9/4
05:31 am
prax
Rating for PRAX
High
Report
Rating for PRAX
9/4
05:31 am
prax
Rating for PRAX
High
Report
Rating for PRAX
9/3
02:08 pm
prax
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
Medium
Report
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
9/3
11:09 am
prax
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $145.00 price target on the stock.
Medium
Report
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $145.00 price target on the stock.
9/3
10:26 am
prax
Rating for PRAX
Low
Report
Rating for PRAX
9/3
10:26 am
prax
Rating for PRAX
Low
Report
Rating for PRAX